Compare CHRW & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CHRW | HOLX |
|---|---|---|
| Founded | 1905 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Medical Electronics |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.4B | 16.6B |
| IPO Year | 1997 | 1990 |
| Metric | CHRW | HOLX |
|---|---|---|
| Price | $175.16 | $75.04 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 21 | 13 |
| Target Price | ★ $158.70 | $77.89 |
| AVG Volume (30 Days) | 1.6M | ★ 2.5M |
| Earning Date | 01-28-2026 | 01-29-2026 |
| Dividend Yield | ★ 1.43% | N/A |
| EPS Growth | ★ 70.68 | N/A |
| EPS | ★ 4.94 | 2.49 |
| Revenue | ★ $16,504,785,000.00 | $4,100,500,000.00 |
| Revenue This Year | N/A | $6.72 |
| Revenue Next Year | $2.81 | $5.48 |
| P/E Ratio | $35.61 | ★ $30.11 |
| Revenue Growth | N/A | ★ 1.74 |
| 52 Week Low | $84.68 | $51.90 |
| 52 Week High | $176.17 | $75.34 |
| Indicator | CHRW | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 72.90 | 61.01 |
| Support Level | $171.50 | $74.72 |
| Resistance Level | $174.25 | $75.17 |
| Average True Range (ATR) | 3.14 | 0.19 |
| MACD | 0.58 | -0.00 |
| Stochastic Oscillator | 99.26 | 83.33 |
C.H. Robinson is a top-tier non-asset-based third-party logistics provider with a significant focus on domestic freight brokerage (about 60% of net revenue), which reflects mostly truck brokerage but also rail intermodal. Additionally, the firm operates a large air and ocean forwarding division (30%), which has grown organically and via tuck-in acquisitions over the years. The remainder of revenue consists of transportation management services and a legacy produce-sourcing operation.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.